Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis
Sign Up to like & getrecommendations! Published in 2025 at "American Journal of Hematology"
DOI: 10.1002/ajh.27716
Abstract: Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging… read more here.
Keywords: progression; renal outcome; progression dialysis; cysc ... See more keywords